Polaryx Therapeutics, Inc. (PLYX): Total Liabilities
$605.0K
As of 2025-12-31
$873.0K
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $605.0K | +109.3% | 2026-03-24, Balance as of period end |
| 2024-12-31 | $289.0K | n/a | 2026-03-24, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | $605.0K | +109.3% |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $2.29M | -87.3% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $1.22M | -26.3% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $4.69M | -37.6% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.99M | +10.1% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $4.58M | -4.7% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $60.59M | +91.1% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $7.40M | +264.3% |
| CDT Equity Inc. (CDT) | 2025-12-31 | $12.82M | +16.7% |
Compare PLYX, PTPI, AZTR, QUCY side by side · Screen every company in Pharmaceutical Preparations ↗